Evrofarma
Evrofarma, Greek dairy, runs vertically integrated Didymoteicho, Evros factory controlling raw materials, selling PDO feta, listed on Athens Exchange.
- Public company
- Didymoteicho, Evros, GRGreece
Evrofarma, Greek dairy, runs vertically integrated Didymoteicho, Evros factory controlling raw materials, selling PDO feta, listed on Athens Exchange.
evrofarma.grCrawled Nov 12, 2026
The investment involves expanding the capacity of the existing dairy production unit.
The company’s 2025 annual general meeting resolutions were adopted on August 5, 2025.
The company produces high-quality dairy products using vertically integrated processes to control raw materials. It aims to create value for consumers and Greek families while respecting people, society, and the environment.
The company ensures its cows receive proper nutrition tailored to their needs, mirroring its commitment to providing high-quality dairy products.
The company is an innovative Greek dairy producer, the largest Greek dairy farmer, and contributes to sustainable development in Thrace.
Evrofarma Viomichania Galaktos publishes a corporate announcement (7925/2026) detailing unspecified updates. The company distributes the information through Public Technologies (PUBT) without modification. The announcement is dated November 6, 2026.
Nov 2026MarketScreenerNews article
Evrofarma Viomichania Galaktos secures regulatory approval for a new pharmaceutical product. The Greek pharmaceutical company, listed on Public Technologies (PUBT), releases the announcement without further details on the specific drug or market impact. The update highlights Evrofarma’s ongoing efforts in drug development and regulatory compliance.
Oct 2026MarketScreenerNews article
Greece’s dairy producers expand exports as Greek yogurt demand surges internationally. The product’s popularity abroad drives growth in the country’s dairy sector, with feta also contributing to export revenues. Producers scale operations to meet rising overseas demand.
Sep 2026tovima.comNews article
Evrofarma Viomichania Galaktos publishes a corporate announcement detailing new initiatives. The company, a Greek pharmaceutical and consumer goods manufacturer, releases an update on its operational and market strategies. The announcement is distributed unedited through Public Technologies (PUBT) on September 4, 2026.
Sep 2026MarketScreenerNews article